INDOCO REMEDIES Share price, NSE/BSE Forecast News and Quotes| Equitymaster

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.

Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks


Login Failure
(Please do not use this option on a public machine)
  Sign Up | Forgot Password?  


Here is the latest stock price and chart of Indoco Remedies. For more details, see the Indoco Remedies company fact sheet and quarterly results. For a sector overview, read our pharmaceuticals sector report.

Live BSE Quotes Sep 25, 2018 03:37:00 PM
Price (Rs)203.30 Open (Rs) 202.50 High (Rs) 204.50 Low (Rs) 200.85
% Change0.35 Volume 5,100 Value (Rs) 1,036,830 52-Week H/L 317.00 / 167.20
Live NSE Quotes Sep 25, 2018 3:29:51 PM
Price (Rs)204.50 Open (Rs) 198.30 High (Rs) 205.20 Low (Rs) 198.30
% Change1.36 Volume 58,569 Value (Rs) 11,936,948 52-Week H/L 317.40 / 166.00
EPS (Rs)* 5.52 P/E Ratio (x) 36.82 Market Cap (Rs m) 18,739.18 P/BV (x) 2.88
  *Trailing 12 months earnings, excluding extraordinary / exceptional items. BSE Sensex | CNX Nifty

Peer Group:
Quote & Graph
Advanced Charts new
Charts by TradingView

INDOCO REMEDIES Share Price Today:

INDOCO REMEDIES last traded price was up 0.3% to Rs 203.3 on the BSE. On the NSE, INDOCO REMEDIES last traded price was up 1.4% to Rs 204.5. The total volume of shares traded was 0.1 m.

Overall, the broader S&P BSE HEALTHCARE Index was up by 1.8%. And the benchmark S&P BSE SENSEX was at 36,652.1 (up 1.0%).

Over the last 30 days, the INDOCO REMEDIES share price is down 0.4%. And over the last one year, INDOCO REMEDIES share price is down 2.4%.

Related Views On News

INDOCO REMEDIES Announces Quarterly Results (4QFY18); Net Profit Up 14.3% (Quarterly Result Update)

Jun 19, 2018 | Updated on Jun 19, 2018

For the quarter ended March 2018, INDOCO REMEDIES has posted a net profit of Rs 205 m (up 14.3% YoY). Sales on the other hand came in at Rs 3 bn (down 2.6% YoY). Read on for a complete analysis of INDOCO REMEDIES's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

Eris Lifesciences Limited (IPO)

Jun 15, 2017

Exposure to high margin specialty products offers promising growth prospects.

More Views on News

Most Popular

My First Pharma Stock Recommendation!(The 5 Minute Wrapup)

Sep 21, 2018

This company has not only created a niche in the pharma space, it has done so profitably.

Want Bigger Returns Than You Thought Possible? This is Where You Should Look(Profit Hunter)

Sep 12, 2018

Richa has discovered the single most profitable opportunity in the market - read on to discover more...

Investors Are Redeeming From Equity Mutual Funds Now. Should You?(Outside View)

Sep 12, 2018

PersonalFN elucidates if you should redeem from equity mutual fund now, and the approach to follow before you decide to sell mutual funds.

Outperformance of Strong Established Brands in the Indian Stock market(Chart Of The Day)

Sep 14, 2018

Strong Well established Indian Brands have comfortably outperformed the index in the decade post the global financial crisis.

How IL&FS Rating Downgrade Will Impact Your Mutual Funds...(Outside View)

Sep 17, 2018

PersonalFN explains the impact of IL&FS rating downgrade on mutual funds.


Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms


  • Track your investment in INDOCO REMEDIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks